FAM
BPMC

Fortaleza Asset Management’s Blueprint Medicines BPMC Stock Holding History

Fortaleza Asset Management’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$65K Sell
1,025
-465
-31% -$37K 0.53% 90
2018
Q1 		$137K Buy
+1,490
New +$128K 0.83% 63

Other funds holding BPMC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Fortaleza Asset Management's BPMC Position: Q2 2018 in Review

Fortaleza Asset Management reduced its Blueprint Medicines (BPMC) stake by 31% in Q2 2018, selling an estimated $37K and leaving 1,025 shares worth $65K. The position accounts for 0.53% of the portfolio, ranked #90.

Fortaleza Asset Management first reported a position in BPMC in Q1 2018 and has held it in 2 quarters since. The position peaked at $137K in Q1 2018. 181 funds tracked by Wall St. Rank hold BPMC as of Q2 2018.

  • Fortaleza Asset Management held 1,025 shares of Blueprint Medicines worth $65K as of Q2 2018.
  • Fortaleza Asset Management sold 465 Blueprint Medicines shares in Q2 2018, an estimated $37K.
  • Blueprint Medicines made up 0.53% of Fortaleza Asset Management's portfolio in Q2 2018, its #90 holding.
  • Fortaleza Asset Management first reported a position in Blueprint Medicines in Q1 2018 and has held it in 2 quarters since.
  • Fortaleza Asset Management's Blueprint Medicines position peaked at $137K in Q1 2018.
  • 181 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2018.

Based on Fortaleza Asset Management's 13F filing for Q2 2018, filed 17 Jul 2018.